Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SPFPL PHARMACIE EFFALA : revenue, balance sheet and financial ratios
SPFPL PHARMACIE EFFALA is a French company
founded 10 years ago,
specialized in the sector Fonds de placement et entités financières similaires.
Based in VIBRAYE (72320),
this company of category PME
shows in 2023 a net income positive of 8 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SPFPL PHARMACIE EFFALA (SIREN 818947822)
Indicator
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
7 892 €
52 192 €
71 998 €
-46 781 €
29 762 €
9 125 €
4 252 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, SPFPL PHARMACIE EFFALA generates positive net income of 8 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 4 k€ -> 8 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
7 892 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 559%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
558.558%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
12.068%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Debt ratio
2188.5
1390.244
612.541
10556.27
1239.512
687.345
558.558
Financial autonomy
3.265
5.316
9.999
0.82
6.494
11.064
12.068
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
558.562023
2021
2022
2023
Q1: 0.02
Med: 13.01
Q3: 113.78
Average
In 2023, the debt ratio of SPFPL PHARMACIE EFFALA (558.56) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
12.07%2023
2021
2022
2023
Q1: 15.8%
Med: 60.29%
Q3: 91.58%
Average
In 2023, the financial autonomy of SPFPL PHARMACIE EFFALA (12.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 103.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
127.695
117.301
347.657
219.847
207.575
187.741
103.356
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
103.362023
2021
2022
2023
Q1: 139.34
Med: 883.94
Q3: 5556.79
Average-6 pts over 3 years
In 2023, the liquidity ratio of SPFPL PHARMACIE EFFALA (103.36) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SPFPL PHARMACIE EFFALA in its sector
Comparison with sector Fonds de placement et entités financières similaires
Valuation estimate
Indicative estimate only : the number of comparable transactions in this sector is limited (25 transactions).
This range of 42 191€ to 120 314€ is provided for information purposes only and requires in-depth analysis to be confirmed.
Estimated enterprise value2023
Indicative
42k€76k€120k€
76 514 €Range: 42 191€ - 120 314€
NAF 5 année 2023
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 25 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Fonds de placement et entités financières similaires)
Compare SPFPL PHARMACIE EFFALA with other companies in the same sector:
Frequently asked questions about SPFPL PHARMACIE EFFALA
What is the revenue of SPFPL PHARMACIE EFFALA ?
The revenue of SPFPL PHARMACIE EFFALA is not publicly disclosed (confidential accounts filed with INPI).
Is SPFPL PHARMACIE EFFALA profitable?
Yes, SPFPL PHARMACIE EFFALA generated a net profit of 8 k€ in 2023.
Where is the headquarters of SPFPL PHARMACIE EFFALA ?
The headquarters of SPFPL PHARMACIE EFFALA is located in VIBRAYE (72320), in the department Sarthe.
Where to find the tax return of SPFPL PHARMACIE EFFALA ?
The tax return of SPFPL PHARMACIE EFFALA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SPFPL PHARMACIE EFFALA operate?
SPFPL PHARMACIE EFFALA operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart